As of mid-August 2026, the CDC has confirmed 2,566 measles cases across 47 jurisdictions, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Trader sentiment reflects sustained transmission driven by declining MMR vaccination coverage—now at 92.4% among kindergartners—and 38 active outbreaks, with 94% of cases linked to these clusters and 93% occurring in unvaccinated or unknown-status individuals. Official data show 19% of cases in children under 5 and 7% hospitalizations, though zero deaths have been reported. Key upcoming catalysts include continued weekly CDC surveillance releases and the Pan American Health Organization’s fall review of U.S. elimination status, which could influence public health responses and case trajectories through year-end.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วผู้ป่วยโรคหัดในสหรัฐอเมริกาในปี 2026?
ผู้ป่วยโรคหัดในสหรัฐอเมริกาในปี 2026?
$7,844,303 ปริมาณ
$7,844,303 ปริมาณ
Dec 30, 2026
↑4.5k
57%
↑3k
97%
↑3.5k
93%
↑4k
81%
↑5k
37%
↑7.5k
12%
↑10k
6%
↑12.5k
6%
$7,844,303 ปริมาณ
$7,844,303 ปริมาณ
Dec 30, 2026
↑4.5k
$28 ปริมาณ
57%
↑3k
$90,886 ปริมาณ
97%
↑3.5k
$14,030 ปริมาณ
93%
↑4k
$228,955 ปริมาณ
81%
↑5k
$231,837 ปริมาณ
37%
↑7.5k
$185,371 ปริมาณ
12%
↑10k
$6,516,697 ปริมาณ
6%
↑12.5k
$350,733 ปริมาณ
6%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC has confirmed 2,566 measles cases across 47 jurisdictions, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Trader sentiment reflects sustained transmission driven by declining MMR vaccination coverage—now at 92.4% among kindergartners—and 38 active outbreaks, with 94% of cases linked to these clusters and 93% occurring in unvaccinated or unknown-status individuals. Official data show 19% of cases in children under 5 and 7% hospitalizations, though zero deaths have been reported. Key upcoming catalysts include continued weekly CDC surveillance releases and the Pan American Health Organization’s fall review of U.S. elimination status, which could influence public health responses and case trajectories through year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ตลาดเปิดเมื่อ: Feb 16, 2026, 11:51 AM ET
ปริมาณการซื้อขาย
$7,844,303วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC has confirmed 2,566 measles cases across 47 jurisdictions, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Trader sentiment reflects sustained transmission driven by declining MMR vaccination coverage—now at 92.4% among kindergartners—and 38 active outbreaks, with 94% of cases linked to these clusters and 93% occurring in unvaccinated or unknown-status individuals. Official data show 19% of cases in children under 5 and 7% hospitalizations, though zero deaths have been reported. Key upcoming catalysts include continued weekly CDC surveillance releases and the Pan American Health Organization’s fall review of U.S. elimination status, which could influence public health responses and case trajectories through year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ปริมาณการซื้อขาย
$7,844,303วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of mid-August 2026, the CDC has confirmed 2,566 measles cases across 47 jurisdictions, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Trader sentiment reflects sustained transmission driven by declining MMR vaccination coverage—now at 92.4% among kindergartners—and 38 active outbreaks, with 94% of cases linked to these clusters and 93% occurring in unvaccinated or unknown-status individuals. Official data show 19% of cases in children under 5 and 7% hospitalizations, though zero deaths have been reported. Key upcoming catalysts include continued weekly CDC surveillance releases and the Pan American Health Organization’s fall review of U.S. elimination status, which could influence public health responses and case trajectories through year-end.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย